171 related articles for article (PubMed ID: 6778941)
1. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
Hoyer LW; Trabold NC
J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
[TBL] [Abstract][Full Text] [Related]
2. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
Switzer ME; McKee PA
J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
[TBL] [Abstract][Full Text] [Related]
3. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
Switzer ME; McKee PA
J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
[TBL] [Abstract][Full Text] [Related]
4. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
Cooper HA; Reisner FF; Hall M; Wagner RH
J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
[TBL] [Abstract][Full Text] [Related]
9. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
Tran TH; Marbet GA; Duckert F
Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
Kirby EP
Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
[TBL] [Abstract][Full Text] [Related]
11. The subunit structure of normal and hemophilic factor VIII.
Shapiro GA; Andersen JC; Pizzo SV; McKee PA
J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
Warren DL; Morrissey JH; Neuenschwander PF
Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
De Cristofaro R; De Filippis V
Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
[TBL] [Abstract][Full Text] [Related]
14. The inactivation of hemostatic factors by hematin.
Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of factor VIII by a mechanism independent of the generation of thrombin.
Triantaphyllopoulos DC
Thromb Haemost; 1979 Oct; 42(3):838-47. PubMed ID: 505401
[TBL] [Abstract][Full Text] [Related]
16. [Contribution to the isolation and study of the molecular weight of human factor VIII].
Mazurier C; Parquet-Gernez A; Goudemand M; Montreuil J
Pathol Biol (Paris); 1975 Dec; 23 suppl():11-6. PubMed ID: 57588
[TBL] [Abstract][Full Text] [Related]
17. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
Vukovich T; Koller E; Doleschel W
Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.
Over J; Bouma BN; van Mourik JA; Sixma JJ; Vlooswijk R; Bakker-Woudenberg I
J Lab Clin Med; 1978 Jan; 91(1):32-46. PubMed ID: 618989
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human procoagulant factor VIII.
Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
Pittman DD; Kaufman RJ
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2429-33. PubMed ID: 3128786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
